Bromopyruvate

N/A

Report date: 2025/06/06 20:01:13
NME

Base Information

Drug NameBromopyruvate
Drug Alias Name3-bromopyruvic acid3-bromopyruvateNSC-62343PSL-0013-BrPA +[11] 
ClassificationSmall molecules
Mechanisms of ActionMannan-binding lectin serine protease 2 inhibitorsPyruvate dehydrogenase complex inhibitorsHexokinase type II inhibitors
TargetsHexokinase type IIMannan-binding lectin serine protease 2Pyruvate dehydrogenase complex
Therapy Area/IndicationsLung NeoplasmsOvarian NeoplasmsPancreatic Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPrimocure PharmaPrescience LabsJohns Hopkins University
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsOvarian NeoplasmsPancreatic Neoplasms +[6] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank